LST for methotrexate in patients with rheumatoid arthritis - Study shows low specificity

Allergy and Clinical Immunology International

Volumn 17, Issue 4, 2005, Pages 156-161

  Hagiwara, Kiyofumi ^a   Sato, Takeo ^a   Yamada, Hirokazu ^b   Yamaguchi, Masao ^b   Akiyama, Osamu ^a   Tomioka, Hisao ^c  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lymphocyte stimulation test; Methotrexate; Rheumatoid arthritis; Specificity; Stimulation index

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; RANK SUM TEST; RHEUMATOID ARTHRITIS; SIDE EFFECT;

EID: 22944487284     PISSN: 08381925     EISSN: None     Source Type: Journal    
DOI: 10.1027/0838-1925.17.4.156     Document Type: Article

References (29)

1. Kremer JM. Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: Follow-up after a mean of 13.3 years. Arthritis Rheum 1997; 40:984-985
2. Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin Arthritis Rheum 2004; 34:465-483
3. Kaito K, Katayama T, Yoshida M. [Fulminant hepatic failure induced by intermediate dose methotrexate in a case of non-Hodgkin's lymphoma.] Rinsho Ketsueki [Jpn J Clin Hematol] 1990; 31:1862-1867 (in Japanese)
4. Kawakami O, Yasuda M, Yamamoto M. [Interstitial pneumonitis following the administration of methotrexate to a patient with rheumatoid arthritis.] Kyushu Ryumachi 1991; 10:155-160 (in Japanese)
5. Okada K, Saito H, Watanabe W. [Anaphylactoid type reaction in two osteosarcoma patients receiving high-dose methotrexate.] Rinsyo Seikeigeka [Jpn J Clin Orthopedic] 1993; 28:859-862 (in Japanese)
6. Bandoh M, Ohno S, Ishii Y, Kitamura S, Abe K, Nokubi M. [A case of drug-induced pneumonitis after low-dose methotrexate therapy.] Kohyu 1996; 15:334-349 (in Japanese)
7. Kaku S. [A patient with non-Hodgkin's lymphoma accompanied by progressive pneumonitis due to methotrexate.] Shindan to Chiryou 1996; 84 (Suppl):694 (in Japanese)
8. Iwasaki Y, Nakagawa M. [A patient with rheumatoid arthritis accompanied by methotrexate induced pneumonitis.] Shindan to Chiryou 1996; 84 (Suppl):708 (in Japanese)
9. Hayakawa M. [A case of methotrexate induced pneumonitis with rheumatoid arthritis.] Nisseki Igaku 1999; 50:339-344 (in Japanese)
10. Ikeda H, Kawano H, Kitaura T Kimura A, Kihira K. Acral erythema associated with high-dose methotrexate infusion. Ann Pharmacol 1999; 33:646
11. Ito S, Nakazono K, Murasawa A, Mita Y, Hata K, Saito N, Kikuchi M, Yoshida K, Nakano M, Gejyo F. Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis Rheum 2001; 44:339-342
12. Matsushima H, Takayanagi N, Kawata I. [Two fatal cases of methotrexate-induced interstitial pneumonitis.] Nihon Kokyuki Gakkai Zasshi 2002; 40:249-255 (in Japanese)
13. Takei Y, Usui N, Hagino T. [Primary central nervous system lymphoma developing methotrexate pneumonitis due to high-dose treatment.] Nihon Kagakuryouhou Gakkai Zasshi 2003; 51: 758-761(in Japanese)
14. Noda M, Honda S, Jinnouchi Y. [RA with severe liver damage following low dose MTX pulse therapy.] Kyushu Ryumachi 2004; 23:175-180 (in Japanese)
15. Kobayashi Y, Yasuba H, Kita H, Chiba W. [A case of interstitial pneumonitis with positive drug lymphocyte stimulation test for metbotrexate using bronchoalveolar lavage fluid lymphocytes.] Kikanshigaku [J Japan Soc Bronchol] 2004; 26:88-91 (in Japanese)
16. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59:809-820
17. Holland P, Mauer AM. Drug-induced in-vitro stimulation of peripheral lymphocytes. Lancet 1964; 18:1368-1369
18. Muto M, Kawachi S, Fukazawa M, Saida T. [Evaluation of diagnostic significance of the drug-induced lymphocyte stimulation test in drug eruptions.] Nihon Hifuka Gakkai Zasshi [Japan J Dermatol] 2000; 110: 1543-1548 (in Japanese)
19. Mantani N, Sakai S, Kogure T. Herbal medicine and false-positive results on lymphocyte transformation test. Yakugaku Zasshi 2002; 122:399-402
20. Uchida S, Kitami N. [Fundamental studies on the lymphocyte stimulation test in patients with drug-induced hepatic injury.] Kanzou 1989; 30: 439-443 (in Japanese)
21. Nowell PC. Inhibition of human leukocyte mitosis by prednisolone in vitro. Cancer Res 1961; 21:1518-1521
22. Kondo A. [Drug-induced pneumonitis.] Kekkaku 1999; 74:33-41 (in Japanese)
23. Maria VA, Victorino RM. Diagnostic value of specific T-cell reactivity to drugs in 95 cases of drug induced liver injury. Gut 1997; 41:534-540.
24. Victorino RM, Maria VA, Pinto LA. Evidence for prostaglandin producing suppressor cells in drug induced hepatitis and implications in the diagnosis of drug sensitization. Clin Exp Immunol 1992; 87:132-137
25. Victorino RM, Maria VA. Drug induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. Lancet 1986; 8491:1209-1210
26. Maurer HR. Potential pitfalls of [3H]thymidine techniques to measure cell proliferation. Cell Tissue Kinet 1981; 14:111-120
27. Hoffmann CC, Ho YK, Blakley RL, Thompson IS. Comparative effects of selected antifolates on transforming human lymphocytes and on established human lymphoblastic cell lines. Biochem Pharmacol 1976; 25: 1947-1954
28. Afane M, Ramos F, Chassagne J, Dubost JJ, Galtier B, Sauvezie B: Discrepancy between 3H-thymidine uptake and cell cycle studies in stimulated lymphocyte cultures treated with methotrexate. Clin Exp Rheumatol 1989; 7:603-608
29. Taheri MR, Wickremasinghe RG, Hoffbrand AV. Alternative metabolic fates of thymine nucleotides in human cells. Biochem J 1981; 194:451-461